All of them with the possible exception of BMY, LLY, and AMGN. For reasons previously posted, my favorite Big Pharma picks are ABT, PFE, and NVS. ABT is more of a force in India than in China, however.
PKI, which is a biotech but not a Big Pharma, is doing very nicely in China (#msg-68686075).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”